Expertise in
3
conditions

Krzysztof W. Selmaj

Olsztyn, WN, PL 
Expertise in
3
conditions
Olsztyn, WN, PL 

Overview

Krzysztof Selmaj practices practicing medicine in Olsztyn, Poland.

Mr. Selmaj is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Relapsing Multiple Sclerosis (RMS), Multiple Sclerosis (MS), CACH Syndrome, and COVID-19.

He is actively involved in clinical research, co-authoring 130 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Olsztyn, WN, Poland
Other Locations
Lodz, LD, Poland
Mazury, PD, Poland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A 2-Year Prospective Study to Assess Health-related Quality of Life In Subjects With Highly-Active Relapsing Multiple Sclerosis Treated With Mavenclad® (CLARIFY MS)
A 2-Year Prospective Study to Assess Health-related Quality of Life In Subjects With Highly-Active Relapsing Multiple Sclerosis Treated With Mavenclad® (CLARIFY MS)
Enrollment Status: Completed
Publish Date: September 14, 2023
Intervention Type: Drug
Study Drug: Mavenclad®
Study Phase: Phase 4
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With an Interferon Beta 1a (Avonex®), in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety
A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared With an Interferon Beta 1a (Avonex®), in Participants With Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety
Enrollment Status: Terminated
Publish Date: August 05, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

130 Total Publications

Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study.
Correction: Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two‑year Phase IV CLARIFY‑MS Study.
Journal: Neurology and therapy
Published: June 01, 2026

Frequently Asked Questions about Krzysztof W. Selmaj

Is Krzysztof W. Selmaj a top-rated expert for Relapsing Multiple Sclerosis (RMS)?

MediFind is an objective health platform that identifies experts based on real-world data. Krzysztof W. Selmaj is classified as an Elite expert for Relapsing Multiple Sclerosis (RMS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Krzysztof W. Selmaj participate in research or clinical trials?

Yes. Krzysztof W. Selmaj has published 130 articles and abstracts on conditions like Relapsing Multiple Sclerosis (RMS). You can view a list of Krzysztof W. Selmaj's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Selmaj's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile